Aldose reductase (AR) inhibitors have considerable therapeutic potential against diabetic complications and do not increase the risk of hypoglycemia. Through bioassay-guided fractionation of the 70% acetone extract obtained from Paulownia coreana seeds, phenylpropanoid glycosides (compounds 1-4) and 5 phenolic coumpounds were isolated (compounds 5-9). Their structures were determined on the basis of spectroscopic analysis and comparison with reported data. All the isolates were subjected to in vitro bioassays to evaluate their inhibitory activities against recombinant human aldose reductase (rhAR) and sorbitol formation in human erythrocytes. Phenylethanoid glycosides showed more effective than the phenolic compounds in inhibiting rhAR. Among the compounds, isocampneoside II (3) was found to significantly inhibit rhAR with an IC 50 value of 9.72 m mM. In kinetic analyses performed using Lineweaver-Burk plots of 1/velocity and 1/concentration of substrate, isocampneoside II (3) showed uncompetitive inhibition against rhAR. Furthermore, it inhibited sorbitol formation in a rat lens incubated with a high concentration of glucose; this finding indicated that isocampneoside II (3) may effectively prevent osmotic stress in hyperglycemia. Thus, the P. coreana-derived phenylethanoid glycoside isocampneoside II (3) may have a potential therapeutics against diabetic complications.
Aldose reductase (EC 1.1.1.21; AR) is a reduced form of nicotinamide adenine dinucleotide phosphate (NADPH)-specific aldo-keto oxidoreductase used to catalyze the conversion of glucose to sorbitol in the polyol pathway, which is the alternate route for the metabolism of a small amount of nonphosphorylated glucose. 1, 2) Because polyols such as sorbitol do not readily move across the cell membranes, they can cause severe osmotic stress, leading to cell swelling and damage. In hyperglycemia, the increased glucose flux enters the polyol pathway; this leads to an overflow of the products of the polyol pathway.
3) Thus, the polyol pathway of glucose metabolism can clarify the involvement of AR in the pathogenesis of diabetic complications. Under hyperglycemic conditions such as those occurring in diabetes mellitus, the capacity of hexokinase to shunt glucose excessively toward glycolysis and other major glucose metabolism pathways is exceeded, resulting in sorbitol accumulation. This excessive accumulation of intracellular sorbitol in the tissues of diabetic animals and in cells cultured under high glucose conditions is an important factor in the pathogenesis of diabetic complications. 4, 5) This sugar alcohol can produce a hyperosmotic effect, a fact known to lead to changes in membrane permeability and the onset of the cellular pathology of diabetes. 5) Although the development and progression of diabetic complications can be prevented by controlling blood glucose, it is difficult to regulate normal blood glucose levels in a diabetic patient. AR inhibition has been recognized as an important strategy for preventing and reducing long-term diabetic complications, and AR inhibitors are being studied as potential therapeutics for diabetic complications. [6] [7] [8] Paulownia coreana is a fast growing tree and has been used in the traditional medicines since ancient times to treat cough, phlegm, carbuncle, hemorrhoid, gonorrhea, and bronchopneumonia. 9) However, there have only been a few studies on the chemistry and biological activity of P. coreana. [10] [11] [12] In this paper, we report the inhibition of AR by the acetone extract of P. coreana, along with the isolation of the active compounds involved and their structure-activity relationships. In addition, we investigated the effects of these compounds on sorbitol accumulation in human erythrocyte.
MATERIALS AND METHODS

Chemicals
The 1 H-and 13 C-NMR spectra were obtained from a Bruker Avance DPX 400 spectrometer at the operating frequency of 400 MHz ( 1 H) and 100 MHz ( 13 C), respectively. Chemical shifts were given in d values with tetramethylsilane as an internal standard. DL-glycealdehyde, the NADPH, and quercetin were purchased from Sigma (St. Louis, MO, U.S.A.). Sephadex LH-20 (GE Healthcare BioScience AB, Sweden) was used as the column packing material. Human recombinant aldose reductase was purchased from Wako Pure Chemical Industries (Osaka, Japan). All other chemicals and reagents were of analytical grade, and commercially available.
Plant Materials The seeds of P. coreana were collected from the experimental forest of Kangwon National University in 2004. It was identified by Prof. Wan-Geun Park of the Department of Forestry. A voucher specimen (No. WSE 0404-5) has been deposited at the herbarium in the Department of Forest biomaterials Engineering, Kangwon National University, Chuncheon, Korea.
Isolation and Identification Air-dried fresh seeds (3.8 kg) of P. coreana were exhaustively extracted with acetone-H 2 O (7 : 3, v/v) for 72 h at room temperature. Combined aqueous acetone solutions were concentrated under reduced pressure and freeze dried. The crude extracts 350 g were suspended in H 2 O and fractionated successively with nhexane, methylene chloride (CH 2 Cl 2 ), ethyl acetae (EtOAc), 
mg).
Assay for Recombinant Human Aldose Reductase (rhAR) Inhibitory Activity rhAR activity was carried out at 37°C in a 100 mM sodium phosphate buffer (pH 6.2) containing 10 mM DL-glyceraldehyde, 0.3 mM NADPH, and rhAR in a total volume of 1.0 ml. The reaction was initiated by recording the decrease in absorbance at 340 nm.
13) The concentration of inhibitors giving IC 50 was calculated from the least-squares regression line of the logarithmic concentrations plotted against the residual activity.
Kinetics of rhAR Inhibition by Active Isolates Reaction mixtures consisted of 0.1 M potassium phosphate (pH 7.0), 0.16 mM NADPH, 2 mM of rhAR with varied concentrations of substrate DL-glyceraldehyde and AR inhibitor, epalrestat in a total volume of 200 ml. Concentrations were ranged from 0.02 to 0.2 mM for DL-glyceraldehyde, from 0.1 to 0.5 mM for active compound. rhAR activity was assayed spectrophotometrically by measuring the decrease in absorption of NADPH at 340 nm after substrate addition using BioTek Power Wave XS spectrophotometer (BioTek Instruments, VT, U.S.A.). 14) Mode of inhibition was determined by Lineweaver-Burk plot analysis of the data, which is calculated from the results according to Michaelis-Menten kinetcs in order to understand the probable mode of action.
Determination of Sorbitol in Human Erythrocytes Human blood was obtained from a healthy male volunteer, who was fully informed of this study and gave written consent. Erythrocytes from heparinized blood were separated from the plasma and buffy coat by centrifuging at 3000 g for 30 min. The cells were routinely washed three times with isotonic saline at 4°C. In the final washing, the cells were centrifuged at 2000 g for 5 min to obtain a consistently packed cell preparation. The packed cells (1 ml) were then incubated in a Krebs-Ringer bicarbonate buffer (pH 7.4) (4 ml) containing 28 mM glucose in the presence or absence of samples at 37°C in 5% CO 2 for 60 min. The erythrocytes were washed with cold saline by centrifuging at 2000 g for 5 min, precipitated by adding 6% of cold perchloric acid (3 ml), and centrifuged again at 2000 g for 10 min. The supernatant was neutralized with 2.5 M K 2 CO 3 at 4°C and used for sorbitol determination. 15, 16) HPLC analysis for sugar alcohol in blood was performed with this supernatant of erythrocytes homogenate after being benzoylated. 17) 
RESULTS AND DISCUSSION
We showed that the 70% acetone extract of P. coreana inhibits the activity of rhAR. To identify the active compounds from the seed of P. coreana, the seed extract was systematically separated into 5 fractions, which were then tested for inhibitory activity against rhAR. Among these fractions, the EtOAc and BuOH fractions exhibited strong inhibitory activity against rhAR with IC 50 values of 2.86 and 3.42 mg/ml, respectively. However, the n-hexane, methylene chloride, and water fractions did not exhibit this activity, as shown in Table  1 . Further chromatographic separation of the active fractions by using Sephadex LH-20 yielded 9 phenolics active against rhAR. Comparing the data from the reference literature, 12, 18, 19) we identified them as verbascoside (1), isoverbascoside (2), isocampneoside II (3), cistanoside F (4), luteolin (5), apigenin (6), kaempferol (7), naringenin (8) , and caffeic acid (9) . The chemical structures of compounds 1-9 isolated from P. coreana seeds are shown in Fig. 1 .
Inhibition of rhAR by compounds 1-9 and by quercetin, a natural aldose reductase inhibitor, was compared. As shown in Table 2 , compounds 1-4, (phenylpropanoid glycosides), had IC 50 values of 18.64, 36.72, 9.72, and 61.52 mM, respectively, and were found to be more effective than the flavonoids and caffeic acid in inhibiting rhAR. Phenylethanoid glycosides are an interesting group of natural products that are widely distributed in the plant kingdom; most of these glycosides are isolated from medicinal plants. 20) They have a common structure which includes a hydroxyphenylethyl b-D-glucopyranoside, which is functionalized with a phenylpropanoic acid (e.g., cinnamic acid, pcoumaric acid, caffeic acid, or ferulic acid) as an ester. They can also have monosaccharide residues such as rhamnose and glucose attached to the glucose moiety. 21) Unlike compounds 1-3, compound 4 is a phenylpropanoid glycoside with a free anomeric hydroxyl group similar to glucose. A comparison of the potency of these 4 compounds, suggested that the dihydroxyphenylethyl moiety was the active compound, because cistanoside F, which lacks this moiety, showed reduced activity. The inhibitory activity of phenylethanoid glycosides against rhAR appears to be related to the presence of the dihydroxyphenylethyl moiety, steric hindrance, and the location of the hydroxyl group. Until now, only compound 1 has been reported to show AR Recombinant human aldose reductase
Verbascoside (1) 18.64 Isoverbascoside (2) 36.72 Isocampneoside II (3) 9.72 Cistanoside F (4) 61.52 Luteolin (5) 12.52 Apigenin (6) 25.32 Kaempferol (7) 45.58 Naringenin (8) 120.63 Caffeic acid (9) 210.28 Quercetin b)
167.88
a) Inhibition rates were calculated as percentages with respect to the control value. The concentration of each test sample giving rise to 50% inhibition of activity (IC 50 ) was estimated from the least-squares regression line of the logarithmic concentration plotted against inhibitory activity. b) Positive control as an inhibitor. inhibitory activity in cattle and rabbit lens. 22, 23) Previous studies have showed that the following relationships may exist between the structure and inhibitory activity of flavonoids: (1) flavones are more active than compounds without the flavonoid skeleton, (2) flavones and flavonols having a catechol moiety show stronger activity; this activity is enhanced by the 2-3 double bond. The inhibitory activities of the 4 flavonoids isolated from P. coreana against rhAR were similar to those previously reported. 24) The inhibitory potency of compounds 5-8 against rhAR was in the following order: flavones (compounds 5, 6)Ͼflavonol (compound 7)Ͼflavanone (compound 8). In particular, compound 5 with a 3Ј,4Ј-dihydroxy moiety in its B ring exhibits more vigorous activity than the compound 6 with a 4Ј-hydroxy group.
In order to determine the type of the inhibition activity of compounds 1-4, a kinetic study was conducted using glyceraldehyde as a substrate (concentration 0.02-0.2 mM), and 2 different concentrations of each compound. The Lineweaver-Burk plots (of 1/velocity and 1/concentration) for compounds 1-4 are shown in Fig. 2 . When the concentration of the substrate DL-glyceraldehyde was changed, the slopes obtained using the uninhibited enzyme and 3 different concentrations of each compound were found to be parallel. The results indicated that the inhibition type of rhAR by isoverbascoside (compound 2) and isocampneoside II (compound 3) was uncompetitive, i.e., these inhibitors could bind neither to the substrate binding region nor to the NADPH binding region of rhAR. Further, verbascoside (compound 1) exhibited a noncompetitive inhibition, whereas cistanoside F (compound 4) showed a competitive inhibition.
In addition, we investigated the effect of phenylethanoid glycosides isolated from P. coreana on the accumulation of sorbitol in human erythrocytes. It has already been reported that AR shows an increased activity in diabetic patients, and the sorbitol levels in rat erythrocytes are positively correlated with the levels in the lens, sciatic nerve, and retina. The effects of compounds 1-4 on sorbitol accumulation in human erythrocytes are shown in Table 3 . Sorbitol accumulation was 14-fold greater when the cells were incubated in high-glucose medium, than when they were incubated in a glucosefree medium. Compounds 1-4 effectively inhibited sorbitol accumulation by almost 70.6, 47.9, 71.3, and 31.7% at 50 mM, respectively. Also, quercetin as a positive control, which inhibits sorbitol accumulation in human erythrocyte by 66.3%, in the culture medium containing a high glucose concentration reduced the sorbitol level.
In this study, we discovered that phenylethanoyl glycosides isolated from P. coreana inhibit rhAR. We also found that phenylethanolyl glycosides significantly suppressed sorbitol accumulation in human erythrocytes. These results indicated that rhAR inhibitors isolated from P. coreana are effective in either preventing or retarding sugar cataract formation associated with diabetes. (4) 20.7Ϯ0.9
Erythrocyte was incubated for 60 min in a Krebs-Ringer bicarbonate buffer containing 28 mM glucose and in the presence or absence of 50 mM compounds. Each value represents the meanϮS.E.M. (nϭ5). a) Quercetin was used as positive control.
